NYSEARCA:BOUT Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News $37.79 -0.35 (-0.92%) Closing price 08/29/2025 04:10 PM EasternExtended Trading$37.79 0.00 (0.00%) As of 08/29/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsBuy This Stock About Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BOUT alerts:Sign Up Key Stats Today's Range$37.68▼$37.7950-Day Range$35.67▼$38.2652-Week Range$31.08▼$42.41Volume781 shsAverage Volume2,004 shsMarket Capitalization$11.34 millionAssets Under Management$11.45 millionDividend Yield0.58%Net Expense Ratio0.85%Aggregate RatingModerate Buy ETF Overview The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator. Read More Innovator IBD Breakout Opportunities ETF ExpensesTypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.80%0.47%0.56%0.51%0.53%Other Expenses0.05%0.49%0.56%0.59%0.56%Total Expense0.85%0.67%0.76%0.74%0.73%Fee Waiver0.00%-0.59%-0.66%-0.71%-0.63%Net Expense0.85%0.53%0.63%0.58%0.60% Receive BOUT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BOUT ETF News HeadlinesOutranking Visa, Mastercard, This Fintech Charges Toward Breakout — With This CaveatAugust 28, 2025 | msn.comDutch Bros: Two Fresh Buy Points Percolating For This Fizzy Growth StockAugust 13, 2025 | msn.comOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.September 1 at 2:00 AM | Crypto 101 Media (Ad)Meta, Microsoft, Google And AppLovin Lead This Breakout WatchAugust 7, 2025 | msn.comTop Funds Savor This Breakout Stock. Here's Why.May 28, 2025 | msn.comBreakout Watch: Top Funds Bet On AI-Fueled Fintech Riding 205% GrowthFebruary 19, 2025 | msn.comSee More Headlines BOUT ETF - Frequently Asked Questions How have BOUT shares performed this year? Innovator IBD Breakout Opportunities ETF's stock was trading at $39.07 on January 1st, 2025. Since then, BOUT stock has decreased by 3.3% and is now trading at $37.79. Who are Innovator IBD Breakout Opportunities ETF's major shareholders? Innovator IBD Breakout Opportunities ETF's top institutional investors include Comprehensive Money Management Services LLC (9.88%) and Nova Wealth Management Inc. (1.66%). How do I buy shares of Innovator IBD Breakout Opportunities ETF? Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Innovator IBD Breakout Opportunities ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), CRISPR Therapeutics (CRSP), Carvana (CVNA), Fastly (FSLY), Luckin Coffee (LKNCY) and Cloudflare (NET). Fund Details IssuerInnovator Capital Management Fund NameInnovator IBD Breakout Opportunities ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BOUT Inception Date9/13/2018 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIBD Breakout Stocks Index CategoryBroad Equity FocusStrategy Development LevelDeveloped Markets RegionNorth America Number of Holdings95 Fund Statistics Assets Under Management$11.45 million Average Daily Volume$1.59 thousand Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorInnovator Capital Management, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares300,000Beta0.98 Creation Unit50,000 Creation Fee$250.00 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report Top 10 BOUT HoldingsBrightSpring Health Services (NASDAQ:BTSG)Holding Weight: 5.33%ResMed (NYSE:RMD)Holding Weight: 5.14%Charles Schwab (NYSE:SCHW)Holding Weight: 5.03%Sportradar Group (NASDAQ:SRAD)Holding Weight: 4.95%Microsoft (NASDAQ:MSFT)Holding Weight: 4.92%MasTec (NYSE:MTZ)Holding Weight: 4.91%Jernigan Capital (NYSE:JCAP)Holding Weight: 4.88%Novartis AG ADRHolding Weight: 4.44%Adtalem Global Education (NYSE:ATGE)Holding Weight: 4.39%APi Group (NYSE:APG)Holding Weight: 4.35%Full Holdings DetailsBOUT Sector ExposureBOUT Industry Exposure This page (NYSEARCA:BOUT) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD Breakout Opportunities ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
